本文選題：乳腺腫瘤　切入點：抗腫瘤聯(lián)合化療方案　出處：《中國臨床醫(yī)學(xué)影像雜志》2017年02期 　論文類型：期刊論文

【摘要】：目的:探討超微血管成像技術(shù)在乳腺癌新輔助化療(Neoadjuvant chemotherapy,NAC)療效評估中的應(yīng)用價值。方法:對57例乳腺癌患者73個腫瘤行NAC前后采用超微血管成像技術(shù)(Superb microvascular imaging,SMI)檢查,對腫瘤最大徑線、血流分級及血流動力學(xué)參數(shù)進行分析。結(jié)果:73個腫瘤NAC后最大徑線較NAC前縮小;行彩色模式SMI檢查顯示化療后血流分級(以0級、Ⅰ級為主)較化療前(以Ⅱ級、Ⅲ級為主)下降,腫瘤內(nèi)血流動力學(xué)參數(shù)Vmax、RI均降低(P0.05)。超聲評價本組中完全緩解21例,部分緩解37例,總有效率79.5%,與病理評價結(jié)果一致性較好。結(jié)論:SMI為臨床評估乳腺癌NAC療效提供了一種無創(chuàng)、快捷、有效的檢查方法。
[Abstract]:Objective: to evaluate the value of supermicrovascular imaging in evaluating the efficacy of neoadjuvant chemotherapy in breast cancer. Methods: supermicrovascular imaging was performed before and after NAC in 57 patients with breast cancer. The maximum diameter, blood flow grade and hemodynamic parameters of the tumor were analyzed. Results: the maximum diameter of 73 tumors after NAC was smaller than that before NAC, and the color mode SMI examination showed the blood flow grade after chemotherapy (grade 0). Compared with those before chemotherapy (grade 鈪，

本文編號：1624091